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INTRODUCTION
Glycan shields reside at the interface between virology, glycobiology, and immunology. Very few pathogens withstand the antibody-mediated onslaught of the humoral immune system, but HIV can. Indeed, despite the presence of high-titer HIV-reactive antibodies, sustained viremia is frequently observed over years of chronic HIV infection (Wei et al., 1995) . The primary mechanism appears to be an evolving glycan shield (Wei et al., 2003) , which couples the typical mutational rate of a small RNA virus (Jenkins et al., 2002) with an extraordinary level of N-linked glycosylation on the HIV-1 envelope (Env) glycoproteins (Allan et al., 1985) , gp120 and gp41, which trimerize to form the HIV-1 viral spike, the only exposed viral antigen on the virion surface (reviewed in Wyatt and Sodroski, 1998) . A median of 93 N-linked glycans (95% CI = 75-105), based on 2,994 Env M-group sequences (www.hiv.lanl.gov), cloak the surface of the trimeric spike and comprise over half its mass (Leonard et al., 1990) (Table S1 ).
Each N-linked glycan is encoded by a tripeptide, Asn-X-Ser/ Thr, the N-glycan sequon (reviewed in Kornfeld and Kornfeld, 1985) , which is recognized by oligosaccharyltransferase on nascent polypeptides as they extrude into the lumen of the endoplasmic reticulum to couple a fully formed Glc 3 Man 9 (GlcNAc) 2 precursor (2371 Da) to Asn in the N-glycan sequon (Hanover and Lennarz, 1980) . The Glc 3 Man 9 (GlcNAc) 2 precursor is trimmed by glycosidases through high mannose forms and then modified by glycosyltransferases, which assemble complex glycans in the Golgi meant for signaling and other glycobiology functions utilized by nearly all secreted or cell-surface-expressed proteins in humans (Varki, 2011) .
Because of their ubiquitous presence, all of these forms of N-linked glycosylation-high mannose through complex-are privileged from antibody recognition through immune tolerance of the functional antibody repertoire. While antibodies can recognize non-self glycans (such as their recognition of the glycan antigens that define the human blood groups) (Stowell et al., 2008) , if antibody recognition of a viral N-linked glycan were to result in cross-recognition of host N-linked glycans, such self-recognition results in the anergy or apoptosis of the N-glycan-reactive B cell (Wardemann et al., 2003) . The upshot is that antibodies only recognize viral N-linked glycans in the context of a viral protein (a glycoprotein epitope) (Kong et al., 2013; McLellan et al., 2011; Pejchal et al., 2011) or in the context of at least two other viral glycans (an exclusively glycan-based epitope) (Sanders et al., 2002; Scanlan et al., 2002) .
The ability of glycan shields to thwart the humoral response is demonstrated in part by their ubiquity-viruses as diverse as hepatitis C virus (HCV; Flaviviridae) (Helle et al., 2011) , Epstein Barr virus (EBV; Herpesviridae) (Szakonyi et al., 2006) , and Lassa virus (LASV; Arenaviridae) (Sommerstein et al., 2015) , along with the aforementioned HIV-1, have extensive N-linked glycosylation, which covers exposed protein surfaces and whose glycan mass can exceed that of the protein component. Of these, the HIV-1 glycan shield is perhaps the most well characterized. Structural studies of the HIV-1 Env trimer or its gp120 subunit have revealed tantalizing glimpses; however, glycosylated gp120 structures lack the interprotomer interactions of the prefusion closed state (Diskin et al., 2013; Kong et al., 2015) , and at best, only about a quarter of the glycan content has been observed with published trimeric structures (Garces et al., 2015; Julien et al., 2013; Kwon et al., 2015; Lee et al., 2015 Lee et al., , 2016 Lyumkis et al., 2013; Pancera et al., 2014; Scharf et al., 2015) (Table S2) . Thus, despite its importance, knowledge of the glycan shield has been primarily antibody-epitope focused, with little understanding of its cumulative characteristics, organizing principles, and overall atomic-level structure. Here, we present the 3.4 Å structure of a fully glycosylated HIV-1 pre-fusion trimer from clade G and characterize the organization of glycans and clustering of oligomannose residues. Additionally, we present the 3.7 Å structures of fully glycosylated HIV-1 pre-fusion trimers from clades A and B and carried out molecular dynamics simulations and other analyses to provide insight into antibodyglycan interactions. The results reveal the HIV-1 glycan shield to comprise prominent ridges of hydrogen-bonded oligosaccharides, ordered by glycan crowding, supported by N-acetylglucosamine stems, and protruding 20 Å above the Env-protein surface; these encase the pre-fusion trimer and enable the critical closed conformation of Env to avoid recognition by most antibody.
RESULTS

Design and Production of Diverse Pre-fusion HIV-1 Trimers
To provide a general understanding of the HIV-1 glycan shield, we sought to determine crystal structures of glycan-shielded Env trimers from diverse HIV-1 clades. The production of prefusion closed trimers from diverse HIV-1 strains has been an obstacle to structural and immunogenicity studies. Sanders et al. (2013) identified a clade A strain (BG505), stabilized by a disulfide (SOS) and isoleucine to proline mutation (IP) and truncated at residue 664, which formed stable soluble trimers. However, when SOSIP mutations were incorporated into other HIV-1 strains, many misfolded or formed aberrant structures, although recently, a few additional well-folded HIV-1 Env strains in the SOSIP context have been identified Julien et al., 2015; Pugach et al., 2015) . As the addition of antibody VRC01 to BaL gp160 HIV-1 virions stabilizes the pre-fusion closed state as assessed by cryo-electron tomography (Tran et al., 2012) , we investigated whether the co-expression of antibody VRC01 with HIV-1 Env trimers might promote formation and stabilization of pre-fusion closed trimers.
To aid in VRC01-trimer complex formation, we designed cysteine mutations across the interface of the heavy chain of antibody VRC01 (A60C HC ) and the CD4-binding site of HIV-1 gp120 (G459C gp120 ) from a range of HIV-1 clades ( Figure S1A ) (for clarity, the molecule is added as subscript, see Supplemental Experimental Procedures). We succeeded in expressing covalent complexes of scFv or Fab VRC01 with SOSIP-stabilized trimers, as stable pre-fusion closed Env trimers from diverse HIV-1 strains (Figures S1B-S1J).
Structure of a Fully Glycosylated HIV-1 Env Trimer from Clade G We observed the lattice formed by antibodies PGT122 and 35O22 in the BG505 SOSIP.664 T332N trimer structure (PDB 4TVP) to be dependent on antibody-antibody contacts ( Figure 1A) , and complexed Fabs PGT122 and 35O22 with fully glycosylated clade G X1193.c1 SOSIP.665 G459C trimers covalently linked with scFv VRC01 (A60C HC ) (Figure S1K) and crystallized in hanging droplets. Data extended to a nominal 3.4 Å resolution, and the structures were refined to an R work /R free of 21.4%/27.2% with an average of 4.8 refined saccharide units/sequon and a solvent-accessible surface area for protein versus carbohydrate of 74,915 Å 2 and 73,948 Å 2 , respectively. (Tables S2, S3 , and S4; Experimental Procedures; Supplemental Experimental Procedures). Electron density was observed for all HIV-1 Env residues between 31 and 665 of strain X1193.c1, except for 3 gp120 C-terminal amino acids of the engineered R 6 furin cleavage site from 508-510. All five variable loops (V1-V5) of gp120 were resolved along with the complete fusion peptide of gp41, which was partially stabilized by an interprotomer interaction with a neighboring gp41 a9 helix ( Figure S2A ). In terms of glycan, ultra-performance liquid chromatography confirmed the N-linked glycan to be primarily high mannose, with Man 5 GlcNAc 2 (Man-5) constituting 31.4% of the glycan and Man-6 and Man-7 being much less predominant than Man-8 and Man-9 (Table S5) . We observed electron density for 29 of the 31 N-linked glycans of X1193.c1 strain, which were distributed across the trimer protein surface ( Figures 1B, S1L , and S1M). 19 of these glycans were largely exposed to the solvent space between individual trimers suspended by the PGT122 and 35O22 Fabs in the crystal lattice ( Figures S1N  and S1O ). Three glycans showed extensive interactions with antibody, including N88 to 35O22, N276 to VRC01, and N332 to PGT122, whereas no glycans were involved in forming crystallization contacts, thereby providing a mostly unperturbed view of the HIV-1 glycan shield. We observed numerous occurrences of glycans organized into discrete structural groups. For example, at the apex of the trimer where the three C-strands of V1V2 associate, glycan N160 was substantially ordered-two N-acetylglucosamines (GlcNAc 2 ) and the b-mannose sugar (Manb) projected perpendicularly 20 Å from the protein surface ( Figure 1B , right insert), with oligomannose branches engaged horizontally, making direct contacts with neighboring N160 oligomanose branches and assembling into an interprotomeric oligomannose ring $15 Å in diameter. The N160 glycans were buttressed by V1 side chains Glu187A and Lys187B, which contacted N160 mannose and N-acetylglucosamine residues, respectively. Additionally, mannose residues of the V1 glycan N188 contacted mannose residues of the N160 glycan ring. The conformation of the N160-glycan ring thus appeared to depend on the V1 sequence, its structure, and its glycosylation.
The N-glycan density on the gp120 outer domain was particularly high ( Figure 1B , left insert). This region contained glycans that were most clearly defined in the electron density (except for glycans bound by antibody). The structure revealed Manb1,4GlcNAcb1,4GlcNAc stems to extend perpendicularly $20 Å from the protein surface, with oligosaccharide branches forming a lateral canopy of glycans that extended from the membrane-proximal 35O22 epitope all the way to the variable loop cover of the trimer apex. In this ridge of interconnected glycans, oligosaccharides showed extensive electron density and allowed five Man-8 and Man-9 glycans to be modeled. However, in other regions such as the glycans from gp41, only two to three sugar residues could be fitted to the electron density. In general, glycans not bound by antibody had B-factors similar to those observed for hypervariable loop residues ( Figures S2B and S2C ).
Structures of Fully Glycosylated HIV-1 Env Trimers from Clades A and B We used the PGT122-35O22-HIV-1 trimer lattice to crystallize a fully glycosylated VRC01-complexed Env trimer from the clade B strain JR-FL, as well as a fully glycosylated Env trimer from the clade A strain BG505 ( Figure S2D ). Diffraction from these crystals extended to nominal resolutions of 3.7 Å , and molecular replacement and refinement led to R work /R free of 25.3%/30.9% and 26.0%/30.7% for JR-FL and BG505, respectively, with an average of 4.6 and 3.8 refined saccharide units/sequon, respectively, and protein verses carbohydrate solvent accessiblesurface area values of 66,575 verses 68,502 Å 2 (JR-FL) and 67,960 verses 60,640 Å 2 (BG505) ( Tables S2, S3 , and S4). Interestingly, despite general similarity of the lattice, the crystallizing antibodies did show strain-dependent variation, such as with N137, a glycan known to be important in PGT122 recognition (Garces et al., 2014 (Garces et al., , 2015 . N137 was disordered in JR-FL (where it is numbered residue N138), ordered in BG505, and displaced by a V1 extension in X1191.c1 ( Figure S2E ). Glycan compositions were high mannose, consistent with the GnTI-deficient cell line used for production, with Man-5 constituting 24.6% and 15.3% of the glycan from JR-FL and BG505 strains, respectively, and with Man-8 and Man-9 dominating over Man-7 and Man-6 (Table S5 and Figure S3A ). The glycan shields of BG505 SOSIP.664 and JR-FL SOSIP.664 revealed varied organizations of glycans on the HIV-1 trimer surfaces (Figures 2A, 2B , and S2F), likely arising from differences in the (B) Crystal structure of a fully glycosylated SOSIP trimer from clade G strain X1193.c1 with gp120 (light gray) and gp41 (dark gray) in ribbon representation and glycans (green) in stick representation. 2Fo-Fc electron density (slate blue) is shown at 0.8 s for glycans; altogether, over half of the carbohydrate has been crystallographically resolved. Insets show select clusters of N-linked glycans, comprising N-acetylglucosamine residues protruding perpendicularly from the protein surface and supporting mannose branches, which form a glycan canopy $20 Å from the protein surface. A view down the 3-fold axis is provided in Figure 2D . See also Figure S1 and Tables S3 and S4. positions of glycan sequons, as well as differences in Env loop lengths and amino acids near N-linked glycans. Stem structures involving Manb1-4GlcNAcb1-4GlcNAc, however, were generally conserved and projected similarly from the protein surface (Figure 2C) , with oligomannose arms forming strain-dependent organizations. Overall, each of the three glycan structures appeared to provide substantial shielding of the pre-fusion HIV-1 Env trimer ( Figure 2D ). The protein structures of the clades A, B, and G Env analyzed here serve to define a conserved pre-fusion HIV-1 Env core (Figures 2E and 2F) , with structural variability for both surface residues and internal residues such as the interhelical region of gp41 (Figures S2A and S2D) . Comparison of the glycan order present in the three gp140 strains showed high correlation between different clades (r = 0.766-0.798) ( Figure 2G ). Thus, the clade A and clade B Env structures confirmed much of the ordered glycan shield observed with the clade G Env structure, and together with the clade G structure defined conserved glycan and protein core structures, as well as variable features.
A Distance-Based Classification of N-Linked GlycanGlycan Interactions Analysis of the inter-sequon neighbor distances revealed glycans on the HIV-1 trimers to have average nearest inter-glycan sequon distance peaking at 12 Å , and we classified these into three categories: (I) 4-7 Å , (II) 9-18 Å , and (III) >20 Å (as measured by glycan sequon Asn Nd2-Nd2 atom distance) ( Figure 3A ). The dispersal of HIV-1 Env glycans was distinct from that observed with other type 1 fusion machines ( Figure 3B ). With HIV-1, a variety of glycan-glycan interactions was observed . In category I, glycans made contacts primarily via GlcNAc stem residues. When glycan sequons were closely juxtaposed (e.g., 4 Å apart), we observed glycan forking (Figure 3C, top left) ; however, when the distance between sequons was slightly increased (e.g., 6 Å apart), glycan stems were observed to align in a parallel manner ( Figure 3C , bottom left). Category II glycans with 9-18 Å inter-sequon distances lacked interactions between GlcNAc 2 stems; rather, GlcNAc 2 stems were generally solvated, with glycan-glycan interactions occurring via oligomannose branches. These generally contacted other oligomannoses (branch-branch engagement), although interactions with GlcNAc 2 stems (stem-branch association) were also observed ( Figure 3C , middle-left panels). More complex associations or network of associations ( Figures S3B-S3D) were observed comprising a variety of interlocking assemblies with two and sometimes three glycans clustering together ( Figure 3C , middle-right panels), and including some long-range interglycan interactions, where sequons can be separated by 30 Å ( Figure 3C , bottom right). Despite the ability of glycans to form long-range interactions, these were not observed with category III glycans. Rather, category III glycans showed electron density for only two or three protein-proximal saccharide units and lacked clearly defined glycan-glycan interactions ( Figure 3C , top right).
The various observed glycan-glycan interactions may inhibit steric access to the protein surface. Steric inhibition might occur though an ''umbrella effect,'' where a single glycan shields a local patch (such as with glycan N197, Figure 3C , top right) through a ''mesh effect,'' where two or more oligosaccharides interact locally (such as with X1193.c1 glycans N241 and N293, Figure 3C , bottom right), or through a ''forest effect,'' where the spacing of sequons forms a substantially interacting glycan shield by creating an oligosaccharide canopy over the protein surface (such as the glycan-shielded apex of X1193.c1, Figure 3C , top middle right). In addition to these ordered effects, the disordered regions of the glycan shield may form entropic or dynamic barriers, inhibiting access to the protein surface of Env.
Surface Glycan Density and Glycan Order
To understand the degree of ordered glycans on these fully glycosylated Env trimers, we investigated parameters that correlated with increased glycan order. The correlation between the number of ordered saccharide units in a glycan versus its nearest neighbor distance was not significant ( Figures S3F-S3H) ; however, we did observe strong correlations between the number of ordered saccharide units and the number of surrounding active sequons within spherical radii ranging from 10 to 55 Å (Figure 4A) . When considering all three Env trimer structures, the Pearson correlation coefficient between the number of ordered saccharide units and the number of active sequons became significant at 20 Å , which may relate to a first shell of supporting glycans, and peaks at a radius of 50 Å , which may include a second shell of supporting glycan ( Figure 4B ). Application of this radial cutoff to each Env trimer structure yielded similar correlations ( Figure S4A ) and allowed for the definition of two distinct classes of glycans: ''crowded'' and ''dispersed,'' based on the number of neighboring sequons and the number of ordered saccharide units. By using Fisher's exact test based on a 2 3 2 contingency table, we determined 15 neighboring sequons to provide the optimal separation between the two classes (see Experimental Procedures for details and Figures S4B and S4C ). Thus, a glycan was classified as being crowded if it had 15 or more neighboring glycans and dispersed if it had fewer than 15 neighboring glycans within a 50 Å radius ( Figures 4C and S4D) .
To visualize differences between the location of crowded and dispersed glycans, we generated protein surface representations, which highlighted the 10 Å vicinity around each glycan sequon. This revealed that crowded glycans generally occupied the membrane-distal region of the Env trimer, as well as the outer ridge of each gp120 (especially the outer domain of gp120), whereas dispersed glycans were generally located in the membrane-proximal region of gp41 ( Figure 4D, top row) . A common feature shared among all three structures was the presence of glycan-free surface (e.g., surface more than 10 Å from any glycan sequon), mostly located within the recessed regions between protruding outer domains. Strong concordance was observed between the three trimer structures for surfaces associated with crowded and dispersed glycans and the number of saccharide units on each sequon, except that sequons in Env variable loops occasionally contained only a few ordered saccharide units, despite being surrounded by crowded glycans ( Figure 4D, bottom row) . Moreover, analysis of M-group Envs showed the pattern of glycan crowding and dispersal observed (D) Crowded and dispersed glycans mapped onto the surface of each Env trimer structure (top row). Crystallographically ordered glycans were also mapped onto the surface of each Env trimer structure (bottom row). N-linked glycans are displayed in stick representation. To enhance visualization, all neighboring residues within 10 Å were also colored accordingly. (E) For each glycan in the three crystallized strains, the corresponding glycan crowding was determined for each of 2994 M-group sequences by threading them onto the BG505, JR-FL, and X1193.c1 structures. Blue dots indicate the median glycan neighbors, thick gray bars indicate the interquartile range, and thin gray bars indicate the 95% range around the median. We found significant correlation between the number of glycan neighbors in the three strains and the median neighbors for M-group sequences. See also Figure S4 .
in the BG505, JR-FL, and X1193.c1 trimer structures to be representative of M-group glycans ( Figures 4E and S4E ).
Molecular Features Associated with Crowded and Dispersed Glycans
To provide additional insight into the biological characteristics of crowded and dispersed glycans, we analyzed the occurrence of crowded and dispersed glycan (and their 10 Å associated surfaces) within the context of the 3-propellar blades of the prefusion closed trimer ( Figure 5A ). Notably, crowded glycans and their 10 Å -associated surfaces were located primarily on convex surfaces of the trimer and covered the entire membrane-distal apex and glycan-V3 region ( Figure 5A , middle left). Half-way down the trimer, the peripheral surfaces of the middle of the trimer were mostly covered by crowded glycan, whereas surfaces closer to the trimer axis were generally not glycosylated (that is, over 10 Å from the nearest glycan sequon) ( Figure 5A , middle right). The membrane-proximal surface of the trimer, which was roughly half the diameter of the trimer middle, was equally covered by all three types of surfaces ( Figure 5A, far right) .
As dense occurrences of glycan are known to inhibit glycan processing (Pritchard et al., 2015) , we would expect glycan processing to be greater with dispersed glycan. We used the glycan type identified on BG505 SOSIP.664 (Guttman et al., 2014) and observed the number of glycan processing steps to be significantly higher for dispersed versus crowded glycan (p = 0.0002, Mann-Whitney test) ( Figure 5B, top left) . We also observed a higher degree of glycan sequon conservation for dispersed glycans compared to crowded glycans (p = 0.0245, Mann-Whitney test) using the glycan types defined from M-group analysis. (Figure 5B , bottom left). Crowded glycans were significantly enriched (p = 0.014, Mann-Whitney test) for glycans showing significant frequency difference between M-group subtypes (27 out of 35), while dispersed glycans were mostly conserved across subtypes ( Figure S5A ). We also assessed surface residues within 10 Å of crowded or dispersed glycans based on M-group analysis and observed surfaceamino acids to be more variable near glycans ( Figure 5B , top right). Broadly neutralizing antibodies showed an increased frequency of recognition near N-linked glycans, with a further increase for regions of crowded glycans ( Figure 5B, bottom right) . Thus, crowded and dispersed glycans are differently ordered, processed, and conserved, with glycosylated regions most frequently recognized by broadly neutralizing antibodies. 
Insight from Molecular Dynamics: Known Broadly Neutralizing Antibody Needs to Accommodate Glycan
To provide additional context for crowded and dispersed glycans, we used the BG505 SOSIP.664 T332N trimer structure to carry out three 500 ns molecular dynamics simulations with either Man-5, Man-7, or Man-9 glycans at every sequon (Movie S1). One distinct feature shared among the glycans was an extended conformation for the Manb-GlcNAc-GlcNAc core at the protein proximal stem. In the crystal structures, this angle was similar for crowded and dispersed glycans, both peaking at 145 and similar to the angle observed from the molecular dynamics simulations ( Figures S5B-S5D , S5F, and S5G). The crowded and dispersed groups displayed substantially different profiles with respect to non-covalent inter-glycan contacts. In all three simulations, dispersed glycans showed a relatively lower number of glycan-glycan contacts, similar to observations in the crystal structures ( Figures S5E-S5G) . Altogether, these results indicate a strong concordance between crystallographic and MD results.
We analyzed the three 500 ns molecular dynamics simulations for glycan overlap of the volumes of bound broadly neutralizing antibodies ( Figures 6A, 6B and S6A-S6D and Table  S6 ). Quantitative analysis of the extent of overlap between the volume occupied by broadly neutralizing antibodies and individual glycans throughout the trajectories ( Figure 6B ) showed concordance among the three fully glycosylated trimer simulations. This analysis also revealed that CD4 and all of the 11 broadly neutralizing antibodies analyzed, including those targeting the CD4-binding site, showed substantial overlap with at least one glycan. The simulation confirmed that antibodies known to require select glycans for recognition (PG9, PGT122, PGT135, PGT151, 8ANC195 and 35O22) did, indeed, have these glycans occupying their bound volumes. CD4-binding site directed antibodies (b12, CH103, HJ16, VRC01, and VRC13) also showed substantial occupation of their bound volumes by up to 9 glycans ( Figures 6B and 6C ). Moreover, atomic-level analysis of the frequency of overlap for required glycans and non-required glycans revealed similar distributions of glycanantibody overlap ( Figure 6D ). These results indicated that known broadly neutralizing antibodies likely need to accommodate at least one glycan.
Insight from Glycan Arrays: Broadly Neutralizing Antibodies Display Sporadic Affinity for Oligosaccharide Antibodies can recognize glycans in a variety of ways, including high-affinity binding of oligosaccharides. We assessed oligosaccharide binding for the 11 antibodies analyzed in Figure 6B , as well as for the 16 CD4-binding site antibodies analyzed previously in the context of the CD4 supersite (Zhou et al., 2015) using an array of 40 oligosaccharides ( Figures 7A and 7B ) containing glycans representative of oligomannose, hybrid, and complextype glycans ( Figure S6E ) (Shivatare et al., 2016) .
Substantial binding was observed for antibodies PGT122 and 35O22 to glycans on the array. While both recognized oligomannose and complex-type glycans ( Figures S6F and S6G ), 35O22 binding appeared to be limited to sialylated complextype glycans, whereas PGT122 recognized both, a preference not entirely explained by electrostatic interactions ( Figures  S6F-S6I) , although a sialic-acid binding site was previously defined for PGT121 (Mouquet et al., 2012) (in this structure, the bound glycan emanates from a neighboring PGT121 Fab in the crystal lattice). Other antibodies (PG9 and PGT151) known to require glycan for recognition displayed interactions with glycans on the array; of the CD4-binding site antibodies, only VRC13 showed significant binding to the glycan array (Figures 7A and 7B) . These results indicated that, while some HIV-1 See also Figure S6 , Table S6 , and Movie S1.
neutralizing antibodies did have direct high affinity for oligosaccharides, many broadly neutralizing HIV-1 antibodies did not have detectable affinity for oligosaccharide in the context of a glycan array. For example, we observed no binding signal for PGT135, which is known to have substantial interaction with N-glycans 332 and 392 in its glycopeptide epitope (Kong et al., 2013) .
Antibody Neutralization and Low Affinity Glycan Interactions
In contrast to the lack of glycan array binding by antibody VRC01 (or by any of the 12 antibodies from the VH-gene specific VRC01 and 8ANC131 classes) (Zhou et al., 2015) See also Figure S7 and Table S6. N462 ( Figure 7F ). Examination of the fully glycosylated crystal structures of VRC01 scFv with pre-fusion closed clade B and clade G Envs indicated little interaction with glycans N197, N363, or N462 ( Figures S7A and S7B ) but substantial interactions with glycan N276, which was highly ordered ( Figure 7C , left, and Figures S7A and S7B ). Similar ordering was previously observed between 45-46m2 and glycan N276 with Env in its receptor-bound conformation (Diskin et al., 2013) , indicating interaction with glycan N276 in both receptor-bound and prefusion closed conformations. We compared the orientations of glycan N276 from the crystal structure of glycosylated BG505 SOSIP.664 T332N, with glycan N276 from the VRC01-bound structures of JR-FL SOSIP.664 and X1193.c1 SOSIP.665 trimers ( Figure 7C, middle and right) . The VRC01-bound structures revealed the N276 glycan to be orientated in a manner compatible with VRC01 antibody access to the CD4-binding site, allowing extensive contacts of the heavy chain with the protein surface of the CD4-binding site. Additionally, comparison of BG505 SOSIP.664 T332N and X1193.c1 SOSIP.665 structures revealed glycan N234 to differ in angle by $49
, apparently re-orientating through a domino effect with glycan N276 in a concerted mechanism with VRC01 binding (Figure 7C , middle).
To determine experimentally whether VRC01 could bind Man 9 GlcNAc 2 Asn, we used saturation transfer difference (STD) NMR, an NMR method that can detect protein-ligand interactions with affinities ranging from nM to mM K d s (McLellan et al., 2011) . Signals belonging to the N-acetyl groups of the core GlcNAc residues yielded observable STD enhancement arising from GlcNAc and mannose ring protons ( Figure 7D ), consistent with VRC01 binding to the conserved GlcNAc-manose core. No STD enhancements were observed in control spectra with a sample containing glycan only. Despite this weak affinity, mutation at VRC01 light chain residues at key contact sites with glycan N276 gave rise to a loss of neutralization ( Figure 7E ). This was also observed in 3BNC117, another VH 1-2-derived antibody that has the same light chain somatic changes as the VRC01-glycan N276 contact residues and other VRC01-like antibodies ( Figures S7C-S7E) (Zhou et al., 2013) . These results suggest light chains from the VRC01 class to have somatically matured to functionally engage glycan N276 directly. Even though the glycan affinity of antibody VRC01 was too weak to be detected with glycan arrays, the VRC01 glycan interactions were nonetheless critical for its neutralization of HIV-1. Thus, while all known broadly neutralizing antibodies that target the shielded pre-fusion closed trimer need to accommodate glycan, glycan-array interactions are often not observed , as antibodies can use a broad range of oligosaccharide affinities to fulfill this requirement.
DISCUSSION
Atomic-level details of glycan shields have long been sought to understand how viruses use glycan to evade host humoral immunity. Here, we provide proof of principle for the ability of the PGT122-35O22 lattice to enable the visualization of fully glycosylated Env trimers from diverse clades. It should be possible to use this lattice or the 3H+109L-35O22 lattice (Garces et al., 2015) to examine different forms of N-linked glycan (e.g., on trimers expressed and processed from T cells) or different types of conformational stabilization (e.g., SOSIP.v1-v4 or DS-SOSIP) Kwon et al., 2015) . Indeed, we have grown crystals of both clade C and 293T-derived BG505 SOSIP with complex sugars (see Supplemental Experimental Procedures), although these crystals need further optimization for atomic-level analysis.
The visualized glycan shields from HIV-1 clades A, B, and G revealed a diversity of glycan conformations and glycanglycan interactions (Figures 1, 2, 3 , and S3B-S3E). A conserved structural motif involved the projection of protein-proximal GlcNAc 2 perpendicular to the protein surface, while proteindistal mannose branches assembled in a variety of ways to form extended canopies of interlocking oligosaccharide arms $20 Å from the protein surface. These glycan orientations differed from N-glycans ordered through interaction with the protein surface (such as glycan N262, in which the GlcNAc stem associates with the protein surface) or from glycans bound by antibody (Kong et al., 2013; McLellan et al., 2011; Pejchal et al., 2011) , which interrupt branch interactions that provide the dominant form of glycan-glycan contact ( Figure 3C ). In general, we would expect the overall glycan orientation and glycan-glycan interactions that we observed here to be representative of dominant low energy ground states, in the same way that crystallographically visualized side chains define amino-acid stereochemistry (Engh and Huber., 1991) . Perhaps relevant to this, visualized glycan residues were often ordered to the same extent as surface amino-acid side chains ( Figures  S2B and S2C) .
Although the surface of HIV-1 Env is perhaps the most genetically diverse region of HIV-1, we observed a number of conserved glycan features between the pre-fusion trimer structures from clades A, B, and G. In particular, we observed similarities in regions of high and low glycan crowding, which appeared general to all of group M ( Figure 4E ), and found regions of high glycan crowding to be correlated with lower glycan conservation, reduced glycan processing, higher Env sequence entropy, and greater serological prevalence of broadly neutralizing antibodies ( Figure 5B ). It remains to be seen if the biological characteristics of crowded and dispersed glycan that we observed with HIV-1 will be conserved in the glycan shields of other viruses.
The combination of structures and molecular dynamics simulations carried out here suggested known broadly neutralizing antibodies that target the pre-fusion closed trimer need to accommodate glycan (Figure 6 ). This glycan requirement may explain the observation that high autologous neutralizing titers against HIV-1 Env trimers stabilized in the pre-fusion closed state require more than 15 weeks to develop (Sanders et al., 2015) , more than 3 times the time required to develop high autologous neutralizing titers against pre-fusion trimers with less glycosylation such as influenza A hemagglutinin. Perhaps relevant to this, tier 2 virus neutralizing antibodies were recently elicited via a naturally occurring N197 glycan-deficient region of a JR-FL immunogen . Moreover, removal of specific glycans has been observed to be critical for interaction of Env with germline versions of some broadly neutralizing antibodies (Correia et al., 2014; Jardine et al., 2013 Jardine et al., , 2015 . Selective removal of glycans obstructing sites of viral vulnerability may thus allow better access to and priming of naïve B cell receptors, which could be matured by boosting with glycan-reverted immunogens (Dosenovic et al., 2015; Jardine et al., 2013 Jardine et al., , 2015 . The diversity that we observed in oligosaccharide recognition by broadly neutralizing antibodies (Figure 7) , however, cautions against relying on any single glycan-modifying strategy as a general means of eliciting broadly neutralizing antibodies against HIV-1; thus, it may be that the presence of particular glycans such as a Man-5 glycan at residue 160 (Doria-Rose et al., 2014) or a high mannose glycan at residue 332 (Garces et al., 2014 (Garces et al., , 2015 Kong et al., 2013) is critical for initiating select B cell lineages. Finally, we note that the knowledge of structurally conserved and variable protein domains from the structures of Env from three diverse clades may help to guide the engineering of genotypically diverse HIV-1 Env trimers, perhaps as artificial chimeric vaccine constructs (Gorman et al., 2016) . The structures of three fully glycosylated Env trimers described here thus not only allow for a definition of the glycan shield but also provide insight into ways the shield might be modified to enhance the elicitation of neutralizing antibody.
EXPERIMENTAL PROCEDURES
HIV-1 gp140 Trimer and Antibody Production HIV-1 gp140 proteins and antibody complexes were expressed in GnTI À/À cells and purified as described previously or by using Ni 2+ and Strep-tag affinity chromatography followed by gel filtration.
PGT122 and 35O22 Fab regions were prepared and purified via size exclusion chromatography (Supplemental Experimental Procedures).
HIV-1 Env Trimer-Fab Complex Preparation and Crystallization
Purified trimers were mixed with purified PGT122 and 35O22 antibody Fabs in a 1:2:2 molar ratio (gp140 protomer:Fab:Fab) and incubated overnight at room temperature. Complexes were further purified by size exclusion chromatography and concentrated to 6-10 mg/ml for crystallization (Supplemental Experimental Procedures).
X-Ray Data Collection, Structure Solution, and Model Building Initial structures were solved by molecular replacement using PDB ID 4TVP coordinates as a starting model . Model re-building and iterative refinement procedures were carried out as described in the Supplemental Experimental Procedures with results shown in Table S3 .
Glycan Analysis by Ultra Performance Liquid Chromatography
Glycosylation profiles of N-linked glycans of purified Env proteins and antibodies were determined by hydrophilic interaction liquid chromatography-ultra performance liquid chromatography (HILIC-UPLC) as previously described (Supplemental Experimental Procedures and Table S5 ).
Saturation-Transfer Difference Nuclear Magnetic Resonance
Binding of VRC01 to Man 9 GlcNAc 2 Asn was detected by NMR using saturation transfer methods as described (McLellan et al., 2011) . Samples were prepared in 20 mM sodium phosphate buffer containing 50 mM sodium chloride at pH 6.8. All experiments were carried out at 298 K (Supplemental Experimental Procedures).
Molecular Dynamics Simulations and Glycan-Antibody Overlap Analysis All molecular dynamics (MD) simulations for the three fully glycosylated BG505 SOSIP.664 trimer models were performed over 500 ns in explicit solvent, and after superimposition of CD4 and 11 antibody structures, all glycan atoms from the MD trajectory within 3.0 Å of the antibody structure were recorded (Supplemental Experimental Procedures and Table S6 ).
Bioinformatics and Definition of Crowded and Dispersed Glycans
Using Fisher's exact test based on a 2 3 2 contingency table, groups were defined as crowded or dispersed depending on the number of neighboring sequons within a spherical shell of 50 Å and the number of saccharide units. 2994 M-group Env sequences from the from the Los Alamos HIV database (www. hiv.lanl.gov) were threaded onto each structure, and the number of neighboring active glycan sequons for each glycan was then determined and was compared to that found for BG505, JR-FL, or X1193.c1 (Supplemental Experimental Procedures).
Fabrication of NHS-Glycan Microarray and Antibody-Glycan Binding Assessment
The 40 glycans used in the array analysis were produced by the modular synthesis method and detailed in the Supplemental Experimental Procedures.
Neutralization Assays BG505, JR-FL, X1193.c1, and T278A variant pseudoviruses were prepared, titered, and used to infect TZM-bl target cells as described in the Supplemental Experimental Procedures.
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